Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 01, 2005 (Vol. 25, No. 3)

Health Informatics jobs, healthcare IT jobs, etc.

  • Broad perspective
  • Scattered
I really like catchy names for Websites, but I wince whenever I see contrived amalgams, such as the one contained in the URL of this site. What is biohealthmatics, you might wonder? Biology, health, and mathematics? No, that would be too simple. Try biomedical informatics. Ouch! Why not call it biomedical informatics? Complaints aside, Biohealthmatics is of note as a career contact point for candidates/companies seeking employment/employees in informatics in the biomedical field. Registration (free for candidates) is required to access information at the site. In addition, the site’s other sections (Bioinformatics Directory, Featured Articles, Forums, News, and Knowledge Center) are all useful, providing easy access to information independent of registration. Though the site overflows with commercial banners from almost all areas of technology, I still give it an overall positive rating.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »